Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adefovir Dipivoxil vs Lamivudine in Compensated Chronic Hepatitis B
NCT00316719Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of adefovir dipivoxil in Chronic Hepatitis B (CHB) (2 arms), sponsored by GSK. Primary endpoint: Mean Change From Baseline in Hepatitis B Virus (HBV) DNA at Week 52. Started Jan 2006; status: completed.
02
Drugs
adefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00316719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00316719.